Related Experiment Video
Updated: Apr 21, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
1.3K
Summary
Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease affecting older adults. Pirfenidone treatment can slow IPF progression and reduce mortality risk in mild to moderate cases.
Area of Science:
- Pulmonology
- Chronic Disease Research
- Medical Diagnostics
Context:
- Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive lung disease predominantly affecting individuals over 60, males, and smokers or ex-smokers.
- Diagnosis relies on identifying usual interstitial pneumonia patterns via imaging or biopsy, excluding other causes, and multidisciplinary expert consensus.
- IPF leads to inevitable chronic respiratory insufficiency, acute exacerbations, and a median survival of approximately 3 years.
Purpose:
- To summarize the current understanding and management of Idiopathic Pulmonary Fibrosis (IPF).
- To highlight diagnostic criteria and therapeutic options for IPF.
- To emphasize the role of early diagnosis and comprehensive care in managing IPF.
Summary:
- Idiopathic pulmonary fibrosis (IPF) is a chronic lung condition common in older males and smokers, diagnosed through specific imaging or biopsy findings.
- The disease progresses to respiratory failure and has a poor prognosis, with a median survival of 3 years.
- Pirfenidone offers a treatment option for mild to moderate IPF, slowing disease progression and improving one-year survival, despite potential side effects.
Impact:
- Pirfenidone treatment demonstrates efficacy in slowing IPF progression and reducing mortality in patients with mild to moderate disease.
- The study underscores the importance of integrating drug therapy into a comprehensive management strategy for IPF.
- Ongoing research focuses on earlier diagnostic methods and novel therapeutic approaches for IPF.
More Related Videos
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.9K
01:23Chronic Obstructive Pulmonary Disease I: Introduction
19
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
19
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
4.0K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
4.0K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
16
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
16
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
23
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
23